Christopher Ruane has been shopping for FTSE 100 bargains amid market turbulence. Here are some of the key things he looks for on the hunt.

Meanwhile, Brunei approved the emergency use of the Sinopharm (BBIBP-CorV), Oxford-AstraZeneca ... Mainland China, the origin point for the pandemic, reported a total of 94% first-dose coverage ...

Singapore is negotiating with the U.S. to ease tariffs on pharmaceuticals and secure access to advanced chips amid shifting ...

Although these tariffs are causing many questions and issues for supply chain management generally, they also pose a number of unique concerns for companies certifying the country of origin of items ...

AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy factory in Maryland to help treat cancer patients. The U.K-based ...

BrahMos is a cutting-edge supersonic cruise missile designed as a joint venture by India and Russia under BrahMos Aerospace. The missile is one of the fastest cruise missiles on the planet and is ...

State officials and AstraZeneca marked the opening Monday of a cell therapy facility in Rockville that aims to create pathways to jobs for the state’s STEM professionals. AstraZeneca completed a ...

HEADQUARTERS IN ROCKVILLE. THIS LAB ISN’T OPEN OR OPERATIONAL YET, BUT ONCE IT IS, THE FOLKS AT ASTRAZENECA BELIEVE IT IS GOING TO REVOLUTIONIZE CANCER TREATMENT. IT GIVES US HOPE. I MEAN.

While iPhones produced in China still account for the majority of US shipments, production in India ramped up after tariffs imposed by the Trump administration. Apple CEO Tim Cook on Thursday ...

AstraZeneca and health-tech company Qure.ai have completed the risk assessment of 5 million artificial intelligence (AI)-enabled chest X-rays (CXRs) across more than 20 countries in Asia, the ...

The S-400 Triumf (NATO designation: SA-21 Growler) is Russia's most sophisticated long-range surface-to-air missile (SAM) system, capable of delivering effective air defense against a broad range ...

May 8 (Reuters) - A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the Medicare health insurance plan the power to negotiate ...